📊 Key financial figures (FY 2024/25) - $SOON (+3,11 %)

• SalesIncrease of 6.6 % to CHF 3.87 billion, exceeding analysts' estimates of CHF 3.84 billion.
• Adjusted EBITA: Increase of 4.7 % to CHF 807.8 million, slightly above the consensus of CHF 804.9 million.
• Gross marginImproved to 71.9 %, an increase of 50 basis points compared to the previous year.
• Organic growth: 4,5 %
• Contribution from acquisitions: 1,4 %

These results reflect a solid performance, particularly in hearing aids, supported by the launch of a new product platform in August.

🔮 Outlook for the 2025/26 financial year

• Sales growthExpected between 5% and 9% at constant exchange rates.
• EBITA growthForecast between 14% and 18%, also at constant exchange rates and adjusted for special effects, but including restructuring costs.

These forecasts are based on the assumption that no additional significant customs duties will be introduced.

👥 Management change

CEO Arnd Kaldowski will step down in September 2025 for personal reasons. Eric Bernard, former CEO of WS Audiology, will take over the position from October 2025.

📈 Market reaction

Sonova's share price performed positively following the publication of the results, indicating investor confidence in the company's strategic direction and future growth prospects.

Overall, Sonova presented solid annual results with a promising outlook for the coming financial year, supported by innovative products and a strategic realignment in management.

Competitors:

$DEMANT (+2,37 %) /$AMP (+0,4 %) / $GN (-1,13 %)

Own investment:

Total: CHF 1,045.72 (x4 shares)

Invested: CHF 936.80

Price gain: CHF 108.92 (11.63 %)

Realized gain: -

Total return: 113.07 CHF

Buy In: 234.20 CHF

Invest is currently not being increased. But I am a big fan, $SOON (+3,11 %) to hold. Hearing aids are not only relevant for the ageing population, but also increasingly the protection of hearing and "perfect enjoyment of sound" as a luxury movement.

April was another exciting month - time for a little tour of my depot and everything around it:

📊 Performance & figures:

• Monthly performance: +1,12 %
• Annual target: +15 %
• Current IPQ: 118,7
• Hot factor favorite: Ferrari 🏎️
• King Midas Factor: Nexus ✨
• My Robo-Advisor continues to perform strongly with an overall performance of +21,61 %
• And the franc? It currently stands at 1,06 €

💻 Crypto & digital assets:

• In my crypto area there were a few adjustments and partial sales.
• At Timeless I have added the Pattex Philippe Calatrava with a discount coupon.
• NFTs: Currently no new developments.
• Music rights via Globalrockstars: No new shares here either.
• Winery news? No news - all quiet in the cellar 🍷

📈 Individual shares, ETFs & savings plans:

• Some ETF savings plans have been paused, but a new savings plan on Cheesecake Factory
  $CAKE (+2,06 %) has been launched.
• Anyone who has been with me for a long time knows my story: I hadn't bought any individual shares for a long time due to additional costs when buying real estate. The buffer has been back since June 2021 - and I'm starting again!
• I'm starting with the "small" stocks from before - not at the same price, but in the same quantity:
• Coloplast$COLO B (+2,38 %)
• Amplifon$AMP (+0,4 %)
• Aston Martin$A5S
• Ceres Power$CWR (-2,6 %)
• Vow$VOW (+12,84 %)
• Vita 34 $V3VJ
• 
  These positions also help me to reduce my loss pot to fill up a little again.

📊 Crowdcube investments:

• A few shares in manga.io secured - the nerd in me needed it. 🎌📚

🎴 Pokémon cards:

• I put together small sets from cards I won - and donated them to a school. Giving back a little piece of joy.

✉️ Application & work:

• April was quiet - one week of vacation, 9 days of overtime reduction, so hardly any time in the clinic.
• Unfortunately, it didn't work out with the 50 % position did not work out.

🏦 Interest & podcast:

• Vivid has adjusted the interest rates - from 10k there is now even a gradation of the interest rate, let's see how long I'll be there.
• 
  Podcast Season 3 Episode 1: Financial goals 🎧

🏠 Real estate:

• The 5% special repayment for 2025 have been saved up - transfer will go out next week. One step closer to being debt-free!

🔮 Outlook for May:

• Portfolio focus: I'm continuing to build my ETF and moving more into individual shares.
• Vacation: At the end of May I'm going to Barcelona for the Formula 1 race. I'll make a detour to the burger chain I bought shares in two years ago - let's see how things go there. 🍔🏁

And you? How was your April?

📌 If you don't like my investments - use the block function. 👍 If you celebrate my ideas - please feel free to follow! Thanks for reading - see you in May! 🙌

Amplifon is making my start to the stock market year. Despite a moderate performance last year, this is one of my favorite stocks on the stock market. After the last quarterly reports, the share fell, although the course of business was actually absolutely fine in my view. For example, a record year was announced for sales, and the company has more stores than ever before. The "threat" of the hearing aid function of the new AirPods added to the negative sentiment. However, I consider both to be an overreaction and hearing aids to be a good investment. We will soon have quite a few old people in many Western countries who may need one or two hearing aids 😬.

Hearing aids